Don’t miss the latest developments in business and finance.

GSK Pharma net up 19% at Rs 114.8 crore

Image
BS Reporter Mumbai
Last Updated : Jan 19 2013 | 10:42 PM IST

The growth in net sales (net of excise and excluding the fine chemicals business) was 11.2 per cent during the quarter ended June 30, 2008. The growth in gross sales (excluding the fine chemicals business) during the first quarter of FY09 was impacted due to lower selling prices as a result of the excise benefit passed on to the consumer, said the company in a release to the Bombay Stock Exchange today.

Also Read

First Published: Jul 28 2008 | 1:29 PM IST

Next Story